EMPOWERMENT:Are there any regulatory hurdles to overcome when using lab-on-a-chip devices in clinical settings?

{
  "winner": 1,
  "reasoning": "NEO provides a comprehensive and detailed explanation of the regulatory considerations for lab-on-a-chip devices, citing specific examples such as fda approval and clia-waived status, and discussing validation, safety, manufacturing standards, and process complexities. in contrast, MS offers only a brief affirmation that regulatory hurdles exist without elaboration or supporting details. therefore, NEO better facilitates understanding and informed judgment by thoroughly explaining the topic."
}
